About Snapback Pharmaceuticals Private Limited
Data last updated:
Snapback Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 28 February 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2022PTC377691.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Rajeev Kumar and Tijender Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 74/II Techno Park C Cross Road MIDC Andheri East Opp. Seepz Gate No. 2, Mumbai, Maharashtra, India – 400093.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.87 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹6.08 Lakh (net margin -14.5%) and EBITDA of -₹4.25 Lakh (EBITDA margin -10.2%).
As per MCA filings, the company has open charges of ₹53 Lakh on record.
For more details, the company can be reached via its website snapbackpharma.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address74/II Techno Park C Cross Road MIDC Andheri East Opp. Seepz Gate No. 2, Mumbai, Maharashtra, India – 400093
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Snapback Pharmaceuticals Private Limited
The main business activity of Snapback Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Snapback Pharmaceuticals Private Limited FY 2025 filings available
Snapback Pharmaceuticals Private Limited reported revenue of ₹41.87 Lakh (down 32% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Snapback Pharmaceuticals Private Limited
Revenue fell 32% in the latest year. EBITDA fell 256% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Snapback Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹4.25 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.08 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Snapback Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -10.2% | •••• | •••• |
| Net Profit Margin | -14.5% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Snapback Pharmaceuticals are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Snapback Pharmaceuticals Private Limited
Snapback Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Winq Cosmetics Private Limited | ₹42.21 Lakh (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Aayu Medisciences Private Limited | ₹42.19 Lakh (FY 2024) | •••• | •••• | -35.0% | •••• | Nagpur, Maharashtra, India |
| Newtech Pharmaceuticals Private Limited | ₹42.14 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Saharanpur, Uttar Pradesh, India |
| Eyesure Vision Care Private Limited | ₹42.04 Lakh (FY 2024) | •••• | •••• | -86.0% | •••• | Main Market Badarpur, Delhi, India |
| Bibso Pharmaceutical Private Limited | ₹41.93 Lakh (FY 2022) | •••• | •••• | 294.0% | •••• | Adityapur, Jharkhand, India |
| Snapback Pharmaceuticals Private Limited this company | ₹41.87 Lakh (FY 2024) | •••• | •••• | -32.0% | •••• | Mumbai, Maharashtra, India |
| San Jigurus Life Sciences Private Limited | ₹41.86 Lakh (FY 2025) | •••• | •••• | -38.0% | •••• | Delhi, India |
| Renascent Bio Care Private Limited | ₹41.85 Lakh (FY 2024) | •••• | •••• | 49.0% | •••• | Pune, Maharashtra, India |
| Medicare Remedies Private Limited | ₹41.85 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Airoli, Maharashtra, India |
| Zambon India Private Limited | ₹41.81 Lakh (FY 2023) | •••• | •••• | -2.0% | •••• | New Delhi, Delhi, India |
| Jibss Vet Pharmaceuticals Private Limited | ₹41.81 Lakh (FY 2024) | •••• | •••• | 35.0% | •••• | Secunderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Snapback Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Snapback Pharmaceuticals Private Limited
Snapback Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Kumar Also directs: Sivia Pharmaceutical Private Limited, NPL Holidays Private Limited | Director | 28 Feb 2022 | 4 Years 7 Months | Current |
| Tijender Kumar | Director | 28 Feb 2022 | 4 Years 7 Months | Current |
Charges & Borrowings of Snapback Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2022 | Others | ₹53 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Snapback Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Snapback Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Snapback Pharmaceuticals Private Limited
Snapback Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Rajeev Kumar was appointed as Director on 28 Feb 2022.
Credit Ratings, Litigation & Regulatory Alerts for Snapback Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Snapback Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Snapback Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Snapback Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Snapback Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Snapback Pharmaceuticals Private Limited
Snapback Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 28 February 2022 (4+ years old) and is registered under CIN U51909MH2022PTC377691.
Snapback Pharmaceuticals reported revenue of ₹41.87 Lakh for FY 2024 (down 32% YoY).
Snapback Pharmaceuticals has 2 current directors:
- Rajeev Kumar - Director
- Tijender Kumar - Director
Snapback Pharmaceuticals reported a net loss of ₹6.08 Lakh (net margin -14.5%) and EBITDA of -₹4.25 Lakh (EBITDA margin -10.2%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Snapback Pharmaceuticals is U51909MH2022PTC377691. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Snapback Pharmaceuticals was incorporated on 28 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Snapback Pharmaceuticals by revenue are Winq Cosmetics Private Limited, Aayu Medisciences Private Limited, Newtech Pharmaceuticals Private Limited, Eyesure Vision Care Private Limited, Bibso Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Rajeev Kumar was appointed as Director on 28 Feb 2022. Tijender Kumar was appointed as Director on 28 Feb 2022.
Snapback Pharmaceuticals can be reached through the website snapbackpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Snapback Pharmaceuticals is at 74II Techno Park C Cross Road MIDC Andheri East Opp. Seepz Gate No. 2, Mumbai, Maharashtra, India – 400093.
Snapback Pharmaceuticals has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh.